ArticleFASEB bioAdvances2026
Unlocking the Power of CXCR2 Inhibition to Overcome Gemcitabine Resistance in Pancreatic Cancer.
Caitlin Molczyk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleFASEB bioAdvances2026
Caitlin Molczyk et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.